1 – 72 of 72
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Novel COMP Neoepitopes Identified in Synovial Fluids from Patients with Joint Diseases using Affinity Chromatography and Mass Spectrometry.
(
- Contribution to journal › Article
-
Mark
Articular cartilage
2014) p.33-41(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
(
- Contribution to journal › Article
- 2012
-
Mark
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment
(
- Contribution to journal › Article
-
Mark
Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases.
(
- Contribution to journal › Article
-
Mark
PRELP Protein Inhibits the Formation of the Complement Membrane Attack Complex
(
- Contribution to journal › Article
-
Mark
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis.
(
- Contribution to journal › Article
- 2011
-
Mark
S100A8/A9 in bleomycin-induced skin fibrosis
2011) 31st European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 70(Suppl. 2).(
- Contribution to journal › Published meeting abstract
-
Mark
The role of the cartilage matrix in osteoarthritis.
(
- Contribution to journal › Article
- 2010
-
Mark
Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training
(
- Contribution to journal › Article
-
Mark
Regulation of complement by COMP allows for a novel molecular diagnostic principle in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Inflammation and joint disease: Molecules/fragments that are released upon cartilage breakdown can activate complement and provide a new diagnostics for pathological complement activation
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
(
- Contribution to journal › Article
- 2008
-
Mark
COMP a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker
(
- Contribution to journal › Article
- 2007
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
- 2006
-
Mark
Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Non-collagenous Proteins; Glycoproteins and related proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Biomarkers for cartilage and bone in rheumatoid arthritis
2006) p.301-301(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Noncollagenous Proteins: Glycoproteins and Related Proteins
2006) p.71-84(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Classification of osteoarthritis biomarkers: a proposed approach
(
- Contribution to journal › Scientific review
-
Mark
The heritable determinants of cartilage oligomeric matrix protein
(
- Contribution to journal › Article
- 2005
-
Mark
Prognostic laboratory markers of joint damage in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2004
-
Mark
Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures.
(
- Contribution to journal › Article
- 2003
-
Mark
Recent developments and future research in the bone and joint decade 2000-2010.
(
- Contribution to journal › Letter
-
Mark
Inflammation is a feature of the disease process in early knee joint osteoarthritis.
(
- Contribution to journal › Letter
-
Mark
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept.
(
- Contribution to journal › Article
- 2002
-
Mark
Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.
(
- Contribution to journal › Article
-
Mark
Markers of joint tissue turnover in osteoarthritis
2002) p.285-292(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Markers of joint tissue turnover in osteoarthritis
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2001
-
Mark
Association of chondroadherin with collagen type II
(
- Contribution to journal › Article
-
Mark
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis
(
- Contribution to journal › Article
- 2000
-
Mark
Diagnosis of osteoarthritis in relation to molecular processes in cartilage: comment on the article by Clark et al.
(
- Contribution to journal › Article
-
Mark
Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis
(
- Contribution to journal › Article
-
Mark
Matrix Glycoproteins and Proteoglycans in Cartilage
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1999
-
Mark
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with osteoarthritis-related type II collagen gene COL2A1 mutation
(
- Contribution to journal › Article
-
Mark
Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis
(
- Contribution to journal › Article
-
Mark
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
(
- Contribution to journal › Article
-
Mark
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
(
- Contribution to journal › Article
- 1998
-
Mark
Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint
(
- Contribution to journal › Article
-
Mark
Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
(
- Contribution to journal › Article
-
Mark
Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study.
(
- Contribution to journal › Article
- 1997
-
Mark
Cartilage macromolecules and the development of new methods for the assessment of joint disease
(
- Contribution to journal › Article
-
Mark
Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis
(
- Contribution to journal › Article
- 1996
-
Mark
Increased concentrations of bone sialoprotein in joint fluid after knee injury
(
- Contribution to journal › Article
- 1995
-
Mark
Authors' reply
(
- Contribution to journal › Article
-
Mark
Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Cartilage and bone metabolism in rheumatoid arthritis: Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism
(
- Contribution to journal › Article
-
Mark
Serum concentrations of two cartilage matrix proteins reflecting different aspects of cartilage turnover in relapsing polychondritis
(
- Contribution to journal › Article
-
Mark
Matrix proteins: Potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis
(
- Contribution to journal › Article
-
Mark
Relationship between serum cartilage oligomeric matrix protein levels and disease progression on osteoarthritis of the knee joint.
(
- Contribution to journal › Article
- 1994
-
Mark
Cartilage metabolism in the injured and uninjured knee of the same patient
(
- Contribution to journal › Article
-
Mark
Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
(
- Contribution to journal › Article
- 1993
-
Mark
Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis
(
- Contribution to journal › Article
- 1992
-
Mark
Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions.
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein. A novel marker of cartilage turnover detectable in synovial fluid and blood
(
- Contribution to journal › Article
- 1991
-
Mark
Connective tissue macromolecules as markers for tissue processes in joint disease.
(
- Contribution to journal › Article
-
Mark
Molecular markers of processes in cartilage in joint disease
(
- Contribution to journal › Article
-
Mark
Macromolecular markers in joint disease
(
- Contribution to journal › Article
- 1989
-
Mark
Involvement of nonarticular cartilage, as demonstrated by release of a cartilage-specific protein, in rheumatoid arthritis.
(
- Contribution to journal › Article
- 1988
-
Mark
Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage.
(
- Contribution to journal › Article
-
Mark
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.
(
- Contribution to journal › Article
-
Mark
Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.
(
- Contribution to journal › Article
-
Mark
Measurement of synovial fluid volume using albumin dilution upon intraarticular saline injection
(
- Contribution to journal › Article
- 1987
-
Mark
Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.
(
- Contribution to journal › Article
-
Mark
Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
(
- Contribution to journal › Article
-
Mark
Cartilage proteoglycans in degenerative joint disease.
(
- Contribution to journal › Article
- 1986
-
Mark
Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.
(
- Contribution to journal › Article
- 1985
-
Mark
Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
(
- Contribution to journal › Article